Lung Cancer-derived Galectin-1 Enhances Tumorigenic Potentiation of Tumor-associated Dendritic Cells by Expressing Heparin-binding EGF-like Growth Factor

EGFR-mutated lung cancer: a paradigm of molecular oncology

(2015)   Oncotarget

VAP-1–Mediated M2 Macrophage Infiltration Underlies IL-1β– but Not VEGF-A–Induced Lymph- and Angiogenesis

(2011) Shintaro Nakao et al.   AMERICAN JOURNAL OF PATHOLOGY

Tumor microenvironment is multifaceted

(2011) Catherine Sautès-Fridman et al.   CANCER AND METASTASIS REVIEWS

Molecular Predictors of Response to Chemotherapy in Non-Small Cell Lung Cancer

(2011) Jenny Andrews et al.   CANCER JOURNAL

The EGFR Ligands Amphiregulin and Heparin-Binding EGF-like Growth Factor Promote Peritoneal Carcinomatosis in CXCR4-Expressing Gastric Cancer

(2011) K. Yasumoto et al.   CLINICAL CANCER RESEARCH

Dendritic Cell-Specific ICAM-3-Grabbing Nonintegrin Expression on M2-Polarized and Tumor-Associated Macrophages Is Macrophage-CSF Dependent and Enhanced by Tumor-Derived IL-6 and IL-10

(2011) A. Dominguez-Soto et al.   JOURNAL OF IMMUNOLOGY

PKCα and PKCδ Regulate ADAM17-Mediated Ectodomain Shedding of Heparin Binding-EGF through Separate Pathways

(2011) Marie Kveiborg et al.   PLoS One

Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17

(2011) Thorsten Maretzky et al.   Nature Communications

B7-H1 Overexpression Regulates Epithelial–Mesenchymal Transition and Accelerates Carcinogenesis in Skin

(2010) Yujia Cao et al.   CANCER RESEARCH

Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy

(2010) Gur Pines et al.   FEBS LETTERS

Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7

(2010) Y. Yin et al.   GUT

HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer

(2010) Fusanori Yotsumoto et al.   INTERNATIONAL JOURNAL OF CANCER

Tumor-Associated a2 Vacuolar ATPase Acts As a Key Mediator of Cancer-Related Inflammation by Inducing Pro-Tumorigenic Properties in Monocytes

(2010) C. Kwong et al.   JOURNAL OF IMMUNOLOGY

Lung Cancer-Derived Galectin-1 Mediates Dendritic Cell Anergy through Inhibitor of DNA Binding 3/IL-10 Signaling Pathway

(2010) P.-L. Kuo et al.   JOURNAL OF IMMUNOLOGY

Enrichment of Foxp3+ CD4 Regulatory T Cells in Migrated T Cells to IL-6- and IL-8-Expressing Tumors through Predominant Induction of CXCR1 by IL-6

(2010) S. Eikawa et al.   JOURNAL OF IMMUNOLOGY

Tumor-Conditioned Macrophages Secrete Migration-Stimulating Factor: A New Marker for M2-Polarization, Influencing Tumor Cell Motility

(2010) G. Solinas et al.   JOURNAL OF IMMUNOLOGY

The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

(2010) Roy M. Bremnes et al.   Journal of Thoracic Oncology

Tumour-microenvironmental interactions: paths to progression and targets for treatment

(2010) Carol Box et al.   SEMINARS IN CANCER BIOLOGY

Progressive Tumor Formation in Mice with Conditional Deletion of TGF-  Signaling in Head and Neck Epithelia Is Associated with Activation of the PI3K/Akt Pathway

(2009) Y. Bian et al.   CANCER RESEARCH

Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands

(2009) Motomichi Nakagawa et al.   CANCER SCIENCE

The chemokine system in cancer biology and therapy

(2009) Alberto Mantovani et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Thromboxane A2 receptor-mediated epidermal growth factor receptor transactivation: Involvement of PKC-δ and PKC-ɛ in the shedding of epidermal growth factor receptor ligands

(2009) Kotomi Uchiyama et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells

(2009) Han Seok Koh et al.   MOLECULES AND CELLS

HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis

(2008) Sandra Sagmeister et al.   JOURNAL OF HEPATOLOGY

Validation of HB-EGF and amphiregulin as targets for human cancer therapy

(2007) Fusanori Yotsumoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS